Globalization of Clinical Trials: Benefits and Risks→

Aparna Shekar1,2, Gerald L. Klein, MD3, and Peter C. Johnson, MD3

1Ph.D. Candidate, Vanderbilt University, Nashville TN, 2Intern, MedSurgPI, LLC., Raleigh NC, 3Principal, MedSurgPI, LLC., Raleigh NC

Erroneous Assumptions in Drug Development→

Roger E. Morgan, MD, Gerald L. Klein, MD, Peter C. Johnson, MD, and Roger Nolan, PhD

Preventing Physician Burnout: Caring for those who care for us→

Aparna Shekar, Ph.D. Candidate; Gerald L. Klein, MD; and Peter C. Johnson, MD

Microbac and MedSurgPI Join Forces to Offer Expansive Product Development Consulting for the Pharmaceutical Market→

FEBRUARY 5, 2018 (PITTSBURGH, PA) – Microbac Laboratories, Inc. today announces a new strategic partnership to offer clients the R&D consulting services of MedSurgPI - a team of commercially experienced pharmaceutical and medical device consultants.

Common Shortfalls in Clinical Supply Chain Planning→

Gerald Klein, MD

AlphaMD and MedSurgPI have entered into a partnership to provide comprehensive Product Development and Commercialization with Medical Affairs Services to clients worldwide.→

This service is a proprietary process to assist start-ups and established Life Science companies launch their drug, diagnostic and medical device products successfully from concept through launch and post-market surveillance. It encompasses proof-of-concept studies, clinical trial assistance, market research, product development, health economics and outcomes research services, a successful launch, data analytics and pharmacovigilance.

The Emergence of Population Health→

by Peter S. Liebert, MD, MBA

The Case for Vendor Oversight for Small Sponsors→

Dawn Edgerton, Gerald L. Klein, MD and Peter C. Johnson, MD

An Interview and Commentary by Kenya Oduor, PhD→

MD to Entrepreneur: From bedside to boardroom

Decreasing Pediatric Asthmatic Hospitalization & Emergency Visits By Improving Adherence→

 Gerald L. Klein, MD Peter C. Johnson MD, Roger Morgan MD

The Pharmacy Adjudicated Clinical Study Supply Process Decreases Risk, Cuts the Cost and Improves the Efficiency when Providing Subjects Unblinded Clinical Study Supplies→

Article by Gerry L. Klein, M.D. & Maxwell O. Clark appearing in: 

The Journal for Clinical Studies | Volume 9, Issue 3 | June 2, 2017

How Best to Leverage Medical Affairs Experts in Life Sciences Companies of Varying Size and Structure→

Shabnam Vaezzadeh, MD, MPA, Gerald L. Klein, MD, Peter C. Johnson, MD, 

Valerie Riddle, MD, Robert L. Wolfert, PhD

Advantages of External Reviews and Audits in Biopharmaceutical Product Development→

Gerald L. Klein, MD (MedSurgPI), Celine Clive (Polaris Compliance Consultants), 

Peter C. Johnson, MD (MedSurgPI), Laurie Meehan (Polaris Compliance Consultants), 

          Roger Morgan, MD  (MedSurgPI) and Valerie Riddle, MD

Building Trust in Pharmaceutical Analytics→

David Lengacher (Rx Solutions), Gerald L. Klein, MD (MedSurgPI LLC), Peter C. Johnson, MD (MedSurgPI, LLC), Roger E. Morgan MD (MedSurgPI, LLC), Valerie Riddle MD and Brent Walter (Rx Solutions)

The Integrated Management Role of the Chief Executive Officer and the Commercial Chief Medical Officer→

Peter C. Johnson, MD*, June S. Almenoff, MD**, PhD and Gerald L. Klein, MD*

MedSurgPI, LLC*, Raleigh, NC and ** Independent Drug Development Consultant, Durham, NC*

The Experienced Medical Monitor: The Role of Virtual and Commercial Medical Monitor→

By Roger E. Morgan MD, Gerald L. Klein, MD, and Peter C. Johnson, MD

Facilitating the Biomedical Key Opinion Leader (KOL) Meeting with a Commercial Chief Medical Officer (CCMO)→

Peter C. Johnson, MD, Gerald L. Klein, MD, Roger E. Morgan, MD MedSurgPI, Raleigh, NC

The Carmen Effect - And the Tyranny of Jargon→

Peter C. Johnson, MD

Decreasing Pediatric Asthmatic Hospitalization & Emergency Visits By Improving Adherence

Gerald L. Klein, MD, Peter C. Johnson MD, Roger Morgan MD